Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions
- Leukemia
- Myelodysplastic Syndromes
Interventions
- DRUG: asparaginase
- DRUG: cytarabine
- DRUG: gemtuzumab ozogamicin
- DRUG: mitoxantrone hydrochloride
Sponsor
Children's Oncology Group
Collaborators